O'Brien Lisa, Jones Daniel J
Occupational Therapy, Monash University, PO Box 527, Frankston, Victoria, Australia, 3199.
Cochrane Database Syst Rev. 2013 Sep 12;2013(9):CD003826. doi: 10.1002/14651858.CD003826.pub3.
Keloid and hypertrophic scars are common and are caused by a proliferation of dermal tissue following skin injury. They cause functional and psychological problems for patients, and their management can be difficult. The use of silicone gel sheeting to prevent and treat hypertrophic scarring is still relatively new and started in 1981 with treatment of burn scars.
To determine the effectiveness of silicone gel sheeting for:(1) prevention of hypertrophic or keloid scarring in people with newly healed wounds (e.g. post surgery);(2) treatment of established scarring in people with existing keloid or hypertrophic scars.
In May 2013 we searched the Cochrane Wounds Group Specialised Register; the Cochrane Central Register of Controlled Trials (CENTRAL); Ovid MEDLINE; Ovid MEDLINE (In-Process & Other Non-Indexed Citations); Ovid EMBASE; and EBSCO CINAHL for this second update.
Any randomised or quasi-randomised controlled trials, or controlled clinical trials, comparing silicone gel sheeting for prevention or treatment of hypertrophic or keloid scars with any other non surgical treatment, no treatment or placebo.
We assessed all relevant trials for methodological quality. Three review authors extracted data independently using a standardised form and cross-checked the results. We assessed all trials meeting the selection criteria for methodological quality.
We included 20 trials involving 873 people, ranging in age from 1.5 to 81 years. The trials compared adhesive silicone gel sheeting with no treatment; non silicone dressing; other silicone products; laser therapy; triamcinolone acetonide injection; topical onion extract and pressure therapy. In the prevention studies, when compared with a no treatment option, whilst silicone gel sheeting reduced the incidence of hypertrophic scarring in people prone to scarring (risk ratio (RR) 0.46, 95% confidence interval (CI) 0.21 to 0.98) these studies were highly susceptible to bias. In treatment studies, silicone gel sheeting produced a statistically significant reduction in scar thickness (mean difference (MD) -2.00, 95% CI -2.14 to -1.85) and colour amelioration (RR 3.49, 95% CI 1.97 to 6.15) but again these studies were highly susceptible to bias.
AUTHORS' CONCLUSIONS: There is weak evidence of a benefit of silicone gel sheeting as a prevention for abnormal scarring in high-risk individuals but the poor quality of research means a great deal of uncertainty prevails. Trials evaluating silicone gel sheeting as a treatment for hypertrophic and keloid scarring showed improvements in scar thickness and scar colour but are of poor quality and highly susceptible to bias.
瘢痕疙瘩和增生性瘢痕很常见,是皮肤损伤后真皮组织增生所致。它们给患者带来功能和心理问题,且治疗起来可能很困难。使用硅胶片预防和治疗增生性瘢痕相对较新,始于1981年对烧伤瘢痕的治疗。
确定硅胶片对以下方面的有效性:(1)预防新愈合伤口(如术后)患者的增生性或瘢痕疙瘩性瘢痕形成;(2)治疗已有瘢痕疙瘩或增生性瘢痕患者的现有瘢痕。
2013年5月,我们检索了Cochrane伤口组专业注册库;Cochrane对照试验中心注册库(CENTRAL);Ovid MEDLINE;Ovid MEDLINE(在研及其他未索引引文);Ovid EMBASE;以及EBSCO CINAHL进行本次第二次更新。
任何随机或半随机对照试验,或对照临床试验,比较硅胶片与任何其他非手术治疗、不治疗或安慰剂预防或治疗增生性或瘢痕疙瘩性瘢痕的效果。
我们评估了所有相关试验的方法学质量。三位综述作者使用标准化表格独立提取数据并交叉核对结果。我们评估了所有符合选择标准的试验的方法学质量。
我们纳入了20项试验,涉及873人,年龄在1.5至81岁之间。这些试验比较了粘性硅胶片与不治疗、非硅胶敷料、其他硅胶产品、激光治疗、曲安奈德注射、局部洋葱提取物和压力治疗。在预防研究中,与不治疗相比,虽然硅胶片降低了易形成瘢痕者增生性瘢痕的发生率(风险比(RR)0.46,95%置信区间(CI)0.21至0.98),但这些研究极易出现偏倚。在治疗研究中,硅胶片使瘢痕厚度有统计学意义的降低(平均差(MD)-2.00,95%CI -2.14至-1.85),颜色改善(RR 3.49,95%CI 1.97至6.15),但同样这些研究极易出现偏倚。
有微弱证据表明硅胶片对高危个体预防异常瘢痕形成有益,但研究质量较差意味着存在很大的不确定性。评估硅胶片治疗增生性和瘢痕疙瘩性瘢痕的试验显示瘢痕厚度和瘢痕颜色有所改善,但质量较差且极易出现偏倚。